Literature DB >> 26377897

Metabolic Reprogramming of Immune Cells in Cancer Progression.

Subhra K Biswas1.   

Abstract

Immune cells play a key role in host defense against infection and cancer. Upon encountering danger signals, these cells undergo activation leading to a modulation in their immune functions. However, recent studies reveal that immune cells upon activation also show distinct metabolic changes that impact their immune functions. Such metabolic reprogramming and its functional effects are well known for cancer cells. Given that immune cells have emerged as crucial players in cancer progression, it is important to understand whether immune cells also undergo metabolic reprogramming in tumors and how this might affect their contribution in cancer progression. This emerging aspect of tumor-associated immune cells is reviewed here, discussing metabolic reprogramming of different immune cell types, the key pathways involved, and its impact on tumor progression.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26377897     DOI: 10.1016/j.immuni.2015.09.001

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  183 in total

Review 1.  Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting.

Authors:  Vijay Kumar
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 2.  Microenvironmental regulation of tumour angiogenesis.

Authors:  Michele De Palma; Daniela Biziato; Tatiana V Petrova
Journal:  Nat Rev Cancer       Date:  2017-07-14       Impact factor: 60.716

Review 3.  Steps in metastasis: an updated review.

Authors:  Jamal Majidpoor; Keywan Mortezaee
Journal:  Med Oncol       Date:  2021-01-04       Impact factor: 3.064

4.  Engineered immune cells as highly sensitive cancer diagnostics.

Authors:  Amin Aalipour; Hui-Yen Chuang; Surya Murty; Aloma L D'Souza; Seung-Min Park; Gunsagar S Gulati; Chirag B Patel; Corinne Beinat; Federico Simonetta; Ivana Martinić; Gayatri Gowrishankar; Elise R Robinson; Eamon Aalipour; Zahra Zhian; Sanjiv S Gambhir
Journal:  Nat Biotechnol       Date:  2019-03-18       Impact factor: 54.908

5.  An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.

Authors:  Ming-Huang Chen; Wen-Chi Chou; Chin-Fu Hsiao; Shih Sheng Jiang; Hui-Jen Tsai; Yi-Chang Liu; Chiun Hsu; Yan-Shen Shan; Yi-Ping Hung; Chia-Hsun Hsich; Chao-Hua Chiu; Ta-Chih Liu; Shih-Feng Cho; Tsang-Wu Liu; Yee Chao
Journal:  Oncologist       Date:  2019-12-18

6.  Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma.

Authors:  Pravin Kesarwani; Antony Prabhu; Shiva Kant; Prakash Chinnaiyan
Journal:  Cancer Immunol Immunother       Date:  2019-05-22       Impact factor: 6.968

Review 7.  Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance.

Authors:  Mark Owyong; Niloufar Hosseini-Nassab; Gizem Efe; Alexander Honkala; Renske J E van den Bijgaart; Vicki Plaks; Bryan Ronain Smith
Journal:  Drug Resist Updat       Date:  2017-10-14       Impact factor: 18.500

8.  Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma.

Authors:  Hweixian Leong Penny; Je Lin Sieow; Giulia Adriani; Wei Hseun Yeap; Peter See Chi Ee; Boris San Luis; Bernett Lee; Terence Lee; Shi Ya Mak; Ying Swan Ho; Kong Peng Lam; Choon Kiat Ong; Ruby Y J Huang; Florent Ginhoux; Olaf Rotzschke; Roger D Kamm; Siew Cheng Wong
Journal:  Oncoimmunology       Date:  2016-06-21       Impact factor: 8.110

9.  Glucose regulates the intrinsic inflammatory response of the heart to surgically induced hypothermic ischemic arrest and reperfusion.

Authors:  Ahmed S Bux; Merry L Lindsey; Hernan G Vasquez; Heinrich Taegtmeyer; Romain Harmancey
Journal:  Physiol Genomics       Date:  2016-12-09       Impact factor: 3.107

10.  IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.

Authors:  Yumeng Mao; Vincent van Hoef; Xiaonan Zhang; Erik Wennerberg; Julie Lorent; Kristina Witt; Laia Masvidal; Shuo Liang; Shannon Murray; Ola Larsson; Rolf Kiessling; Andreas Lundqvist
Journal:  Blood       Date:  2016-07-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.